Aguiar, T., Mashiko, S., Asam, K., Roy, P., Wang, S., Frank, K., Dietzel, M., Schahadat, L. G. Z., Ausmeier, M., Hertel, A., Duan, Z. R. S., Aouizerat, B., Genkinger, J. M., Remotti, H., & Zorn, E. (2025). Development of high-titer class-switched antibody responses to phosphorylated amino acids is prevalent in pancreatic ductal adenocarcinoma. Frontiers in Immunology, 16. https://doi.org/10.3389/fimmu.2025.1501943

Fontana, M., Maurer, M. S., Gillmore, J. D., Bender, S., Aldinc, E., Eraly, S. A., Jay, P. Y., & Solomon, S. D. (2024). Outpatient Worsening Heart Failure in Patients with Transthyretin Amyloidosis with Cardiomyopathy in the HELIOS-B Trial. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2024.11.015

Zhang, Y., Karagiannis, D., Liu, H., Lin, M., Fang, Y., Jiang, M., Chen, X., Suresh, S., Huang, H., She, J., Shi, F., Liu, J., Luo, D., Angel, J. C., Lin, G., Yang, P., El-Rifai, W., Zaika, A., Oro, A. E., … Que, J. (2024). Epigenetic regulation of p63 blocks squamous-to-neuroendocrine transdifferentiation in esophageal development and malignancy. Science Advances, 10(41). https://doi.org/10.1126/sciadv.adq0479

Neugut, A. I., & Bates, S. E. (2024). Highlights of ASCO 2024. The Oncologist, 29(11), 913–917. https://doi.org/10.1093/oncolo/oyae250

Jamison, J. K., Zhou, M., Gelmann, E. P., Luk, L., Bates, S. E., Califano, A., & Fojo, T. (2024). Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumors. The Oncologist. https://doi.org/10.1093/oncolo/oyae118

Elmi, N., McEvoy, D., McInnes, M. D. F., Alabousi, M., Hecht, E. M., Luk, L., Asghar, S., Jajodia, A., de Carvalho, T. L., Warnica, W. J., Zha, N., Ullah, S., & van der Pol, C. B. (2023). Percentage of Pancreatic Cysts on MRI With a Pancreatic Carcinoma: Systematic Review and Meta‐Analysis. Journal of Magnetic Resonance Imaging. Portico. https://doi.org/10.1002/jmri.29168

Lee, E., O’Keefe, S., Leong, A., Park, H.-R., Varadarajan, J., Chowdhury, S., Hiner, S., Kim, S., Shiva, A., Friedman, R. A., Remotti, H., Fojo, T., Yang, H. W., Thurston, G., & Kim, M. (2023). Angiopoietin-2 blockade suppresses growth of liver metastases from pancreatic neuroendocrine tumors by promoting T cell recruitment. Journal of Clinical Investigation, 133(20). https://doi.org/10.1172/jci167994

Safari, M., Scotto, L., Litman, T., Petrukhin, L. A., Zhu, H., Shen, M., Robey, R. W., Hall, M. D., Fojo, T., & Bates, S. E. (2023). Novel Therapeutic Strategies Exploiting the Unique Properties of Neuroendocrine Neoplasms. Cancers, 15(20), 4960. https://doi.org/10.3390/cancers15204960

Kimura, N., Hirata, Y., Iwashiro, N., Kijima, H., Takayasu, S., Yamagata, S., Sakihara, S., Uchino, S., & Ohara, M. (2023). Multiple endocrine neoplasia type 1 with Zollinger–Ellison syndrome: clinicopathological analysis of a Japanese family with focus on menin immunohistochemistry. Frontiers in Endocrinology, 14. https://doi.org/10.3389/fendo.2023.1221514

Connelly, C., Towne, W., Smithgall, M., Cimic, A., & Baskota, S. U. (2023). Pan-TRK Immunostain for Primary Pancreaticobiliary Carcinomas in Cell Block: A Detailed Study of 233 Cases. Journal of the American Society of Cytopathology, 12(5), S47. https://doi.org/10.1016/j.jasc.2023.07.083

Ko, A. H., Kim, K.-P., Siveke, J. T., Lopez, C. D., Lacy, J., O’Reilly, E. M., Macarulla, T., Manji, G. A., Lee, J., Ajani, J., Alsina Maqueda, M., Rha, S.-Y., Lau, J., Al-Sakaff, N., Allen, S., Lu, D., Shemesh, C. S., Gan, X., Cha, E., & Oh, D.-Y. (2023). Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform. The Oncologist, 28(6), 553-e472. https://doi.org/10.1093/oncolo/oyad022

Farha, N., Wei, W., Mundi, P., Krishnamurthi, S., Steele, S., Kamath, S., Gorgun, E., Liska, D., Estfan, B., Khorana, A., & Laderian, B. (2023). P-273 Genomic signatures associated with aggressive histology and decreased overall survival in neuroendocrine malignancies. Annals of Oncology, 34, S112. https://doi.org/10.1016/j.annonc.2023.04.329

Laderian, B., Wei, W., Farha, N., Mundi, P., Rao, P., Balagamwala, E., Steele, S., Vijayvergia, N., Sadaps, M., Chandrasekharan, C., Mohamed, A., & Pacak, K. (2023). P-136 Increased healthcare costs due to diagnostic imaging services following false elevation of plasma chromogranin A and 24-hour urinary 5-hydroxyindoleacetic acid: A quality improvement project. Annals of Oncology, 34, S63. https://doi.org/10.1016/j.annonc.2023.04.192

Perez, K., Chiarella, A. M., Cleary, J. M., Horick, N., Weekes, C., Abrams, T., Blaszkowsky, L., Enzinger, P., Giannakis, M., Goyal, L., Meyerhardt, J. A., Rubinson, D., Yurgelun, M. B., Goessling, W., Giantonio, B. J., Brais, L., Germon, V., Stonely, D., Raghavan, S., … Wolpin, B. M. (2023). Phase Ib and Expansion Study of Gemcitabine,Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer. The Oncologist, 28(5), 425–432. https://doi.org/10.1093/oncolo/oyad002

Fulop, D. J., Zylberberg, H. M., Wu, Y. L., Aronson, A., Labiner, A. J., Wisnivesky, J., Cohen, D. J., Sigel, K. M., & Lucas, A. L. (2023). Association of Antibiotic Receipt With Survival Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Receiving Chemotherapy. JAMA Network Open, 6(3), e234254. https://doi.org/10.1001/jamanetworkopen.2023.4254

Bhalla, A., Liu, Q., Fang, Y., & Lefkowitch, J. H. (2023). IgG4 plasma cell neoplasm in liver transplant biopsy masquerading as rejection. Leukemia Research Reports, 20, 100379. https://doi.org/10.1016/j.lrr.2023.100379

Minnema, M. C., Dispenzieri, A., Merlini, G., Comenzo, R. L., Kastritis, E., Wechalekar, A. D., Grogan, M., Witteles, R., Ruberg, F. L., Maurer, M. S., Tran, N., Qin, X., Vasey, S. Y., Weiss, B. M., Vermeulen, J., & Jaccard, A. (2022). Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis. JACC: CardioOncology, 4(4), 474–487. https://doi.org/10.1016/j.jaccao.2022.08.011

Caplan, L. R., Vavinskaya, V., Gelikman, D. G., Jyotsana, N., Trinh, V. Q., Olive, K. P., Tan, M. C. B., & DelGiorno, K. E. (2022). Enteroendocrine Cell Formation Is an Early Event in Pancreatic Tumorigenesis. Frontiers in Physiology, 13. https://doi.org/10.3389/fphys.2022.865452

Gregory, G. P., Kumar, S., Wang, D., Mahadevan, D., Walker, P., Wagner-Johnston, N., Escobar, C., Bannerji, R., Bhutani, D., Chang, J., Hernandez-Ilizaliturri, F. J., Klein, A., Pagel, J. M., Rybka, W., Yee, A. J., Mohrbacher, A., Huang, M., Farooqui, M., Marinello, P., & Quach, H. (2022). Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study. Blood Advances, 6(4), 1232–1242. https://doi.org/10.1182/bloodadvances.2021005872